Codexis (CDXS) Current Assets (2010 - 2026)
Codexis (CDXS) recorded quarterly Current Assets of $79.6 million in Q1 2026, down 17.73% quarter-over-quarter from $96.8 million in Q4 2025, and up 2.37% on a YoY basis from $77.8 million in Q1 2025.
Codexis (CDXS) Current Assets (2010 - 2026) Analysis & Trends
Codexis' Current Assets history runs 17 years deep, the most recent figure standing at $79.6 million for Q1 2026.
- In Q1 2026, Current Assets rose 2.37% year-over-year to $79.6 million; the TTM figure through Mar 2026 stood at $79.6 million (up 2.37% YoY), while the FY2025 annual figure was $96.8 million, down 1.98% from the prior year.
- Current Assets was $79.6 million for Q1 2026 at Codexis, down from $96.8 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $162.9 million in Q4 2022 to a low of $76.2 million in Q3 2025.
- Historically, Current Assets has averaged $110.3 million across 5 years, with a median of $103.0 million in 2023.
- The sharpest annual moves came in 2023 and 2024: Current Assets plunged 42.62% in 2023, then increased 9.6% in 2024.
- A 5-year view of Current Assets shows it stood at $162.9 million in 2022, then plunged by 42.62% to $93.5 million in 2023, then grew by 5.68% to $98.8 million in 2024, then fell by 1.98% to $96.8 million in 2025, then declined by 17.73% to $79.6 million in 2026.
- The last three Current Assets figures came in at $79.6 million (Q1 2026), $96.8 million (Q4 2025), and $76.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 3.59 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 600.85 Mn |
| 10 | Codexis | 236.00 Mn | 170.86 Mn | 13.18 Mn | 79.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 79.65 Mn |
| Dec 31, 2025 | 96.82 Mn |
| Sep 30, 2025 | 76.19 Mn |
| Jun 30, 2025 | 88.73 Mn |
| Mar 31, 2025 | 77.81 Mn |
| Dec 31, 2024 | 98.77 Mn |
| Sep 30, 2024 | 112.90 Mn |
| Jun 30, 2024 | 91.40 Mn |
| Mar 31, 2024 | 107.95 Mn |
| Dec 31, 2023 | 93.47 Mn |
| Sep 30, 2023 | 103.01 Mn |
| Jun 30, 2023 | 120.04 Mn |
| Mar 31, 2023 | 129.95 Mn |
| Dec 31, 2022 | 162.89 Mn |
| Sep 30, 2022 | 146.00 Mn |
| Jun 30, 2022 | 145.28 Mn |
| Mar 31, 2022 | 144.87 Mn |
| Dec 31, 2021 | 161.89 Mn |
| Sep 30, 2021 | 174.11 Mn |
| Jun 30, 2021 | 172.40 Mn |